Healthcare Services

Near-Patient Molecular Solutions Market Insights Exploring Expansion Opportunities Through 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Value Of The Near-Patient Molecular Solutions Market Projected To Expand During 2026–2030?

The near-patient molecular solutions market has demonstrated robust expansion over recent years. It is projected to grow from $4.54 billion in 2025 to $4.99 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.8%. The historic growth in this market can be ascribed to the increasing use of molecular diagnostic techniques, the need for faster test results, the decentralization of laboratory services, the development of outpatient diagnostic environments, and the integration of portable diagnostic instruments.

The near-patient molecular solutions market is projected to experience substantial expansion in the coming years. By 2030, this market is forecast to reach $7.17 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. This anticipated growth is primarily driven by several factors, including an intensified focus on personalized medicine, a growing need for home and remote testing options, innovations in miniaturized molecular platforms, the broadening scope of infectious disease surveillance, and better integration with digital health ecosystems. Key trends expected during this period involve the wider adoption of point-of-care molecular testing devices, an escalating requirement for swift infectious disease diagnostics, the increasing incorporation of portable PCR platforms, the development of decentralized diagnostic infrastructure, and a heightened emphasis on the precision of near-patient testing.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

Which Growth Drivers Are Expected To Support The Near-Patient Molecular Solutions Market Forward?

The increasing need for home-use point-of-care devices is anticipated to drive the expansion of the near patient molecular solutions market in the future. These home-based point-of-care devices are diagnostic tools utilized by individuals or non-professionals at or close to their residences, facilitating sample gathering, analysis, or result interpretation away from a standard central laboratory environment and directly at the point of care. The heightened demand for such devices stems from consumers’ growing preference for health monitoring that is convenient, quick, and readily available beyond conventional medical facilities. Near-patient molecular solutions contribute to home-based point-of-care devices by offering precise, fast, and portable molecular diagnostic capabilities that are dependable for use outside typical laboratory environments. As an illustration, in February 2023, the US Food & Drug Administration (FDA), a US-based government agency, noted in its 2023 COVID-19 testing update that authorizations included one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Consequently, the escalating demand for home-based point-of-care devices is fueling the expansion of the near-patient molecular solutions market.

Which Segment-Based Categories Are Covered In The Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

Which Trends Are Guiding The Development Of The Near-Patient Molecular Solutions Market?

Leading firms within the natural insect repellents market are concentrating on creating novel formulations, like mosquito-repellent sprays, to offer instant defense against mosquito bites, thereby aiding in the reduction of insect-borne disease risks. These sprays are either aerosol or liquid applications formulated to deter mosquitoes from biting through the application of a protective layer of active components onto the skin or adjacent surfaces. An example is Diptyque, a France-based luxury fragrance brand, which introduced a body spray with mosquito-repellent qualities in June 2023. This limited-edition perfuming summer body spray combines utility with indulgence, presenting a distinct blend of essential oils recognized for their mosquito-repellent attributes, such as lemongrass, geranium, and lemon eucalyptus. These oils are smoothly integrated with the invigorating, aromatic notes of neroli and orange blossom, yielding a vibrant and floral scent that simultaneously assists in mosquito protection.

Which Organizations Are Involved In The Near-Patient Molecular Solutions Market?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Access The Complete Near-Patient Molecular Solutions Market Report:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Which Regional Market Leads The Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Near-Patient Molecular Solutions Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=30333&type=smp

Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company

Household Insecticides Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Edible Insects Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report

Tick Repellent Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/tick-repellent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795